Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Bicarbonate Eyed as Weapon to Combat 2 Most Prevalent Bacteria in CF What You Need to Know About Romance, or the Lack of, When You Have CF Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments New Approach Against Antibiotic-resistant Bacteria in CF Patients Shows Promise in Phase 1 Trial

Bicarbonate Eyed as Weapon to Combat 2 Most Prevalent Bacteria in CF Oct 10, 2018 07:00 am | Patricia Inacio, PhD Adding bicarbonate, a salt, to the culture medium of Pseudomonas aeruginosa and Staphylococcus aureus, two of the most common bacteria underlying lung infections in people with cystic fibrosis (CF), impairs the bacteria’s growth, a study shows. This finding supports the potential use of inhaled bicarbonate as a therapy for CF. The study “Bicarbonate Inhibits Bacterial Growth […] The post Bicarbonate Eyed as Weapon to Combat 2 Most Prevalent Bacteria in CF appeared first on Cystic Fibrosis News Today. Read More What You Need to Know About Romance, or the Lack of, When You Have CF Oct 09, 2018 09:00 am | Brad Dell I’ve been single for a year now, and I’m darn proud of it. I didn’t think I could do it, and I’ve grown so much because of it. From ages 17 to 24, I was with a wonderful person. It was us against the destructive titan, cystic fibrosis. We fought side by side, not against […] The post What You Need to Know About Romance, or the Lack of, When You Have CF appeared first on Cystic Fibrosis News Today. Read More Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments Oct 09, 2018 08:00 am | Larry Luxner Half a year has gone by since disgraced pharma executive Martin Shkreli was sentenced to seven years in federal prison for securities and wire fraud while heading San Diego-based Retrophin. As founder and CEO of another company (then known as Turing Pharmaceuticals), in late 2015 Shkreli bought the rights to the off-patent medication Daraprim (pyrimethamine),which […] The post Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatmentsappeared first on Cystic Fibrosis News Today. Read More New Approach Against Antibiotic-resistant Bacteria in CF Patients Shows Promise in Phase 1 Trial Oct 09, 2018 07:00 am | Ana Pena Researchers may have found a new way of treating antibiotic-resistant bacterial infections, specifically Pseudomonas aeruginosa, in the airways of patients with cystic fibrosis (CF), a study shows. In a preliminary Phase 1 trial, a single five-day infusion with the potential treatment, called gallium nitrate, improved the lung function of CF patients with a chronic P. aeruginosa infection, […] The post New Approach Against Antibiotic-resistant Bacteria in CF Patients Shows Promise in Phase 1 Trial appeared first on Cystic Fibrosis News Today. Read More

Recent News Please Don’t Label Me as Sick Nutritional Well-Being After Transplant Measure of Likely Lung Health, Study Finds Corbus Awarded US Patent Covering Lenabasum as Potential CF and Fibrotic Disease Treatment Antibiotics Make Bacteria More Resistant by Lowering Microbial Diversity in Lungs, Study Suggests Agreement Readies Denmark, Austria for Approval of Vertex CF Therapies